Literature DB >> 18612991

Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions.

Virginia Cecconi1, Monica Moro, Sara Del Mare, Paolo Dellabona, Giulia Casorati.   

Abstract

MHC-class I tetramers technology enabled the characterization of peptide-specific T cells at the single cell level in a variety of studies. Several laboratories have also developed MHC-class II multimers to characterize Ag-specific CD4+ T cells. However, the generation and use of MHC-class II multimers seems more problematic than that of MHC-I multimers. We have generated HLA-DR*1101 tetramers in a versatile empty form, which can be loaded after purification with peptides of interest. We discuss the impact of critical biological and structural parameters for the optimal staining of Ag-specific CD4+ T cells using HLA-DR*1101 tetramers, such as: (i) activation state of CD4+ T cells; (ii) membrane trafficking in the target CD4+ T cells; (iii) binding characteristics of the loaded CD4 epitope. Our data indicate that reorganization of TCR on the plasma membrane upon CD4+ T cell activation, as well as an homogenous binding frame of the CD4 epitopes to the soluble HLA-DR monomer, are critical for a stable TCR/MHC-class II tetramer interaction. These factors, together with the low frequencies and affinities of specific CD4+ T cells, explain the need for in vitro expansion or ex vivo enrichment of specific T cells for the optimal visualization with MHC-class II tetramers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612991     DOI: 10.1002/cyto.a.20603

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  16 in total

1.  MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer.

Authors:  Caroline Poli; Caroline Raffin; Danijel Dojcinovic; Immanuel Luescher; Maha Ayyoub; Danila Valmori
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

2.  In situ detection of autoreactive CD4 T cells in brain and heart using major histocompatibility complex class II dextramers.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Ting Jia; Christian Elowsky; Qingsheng Li; You Zhou; Jay Reddy
Journal:  J Vis Exp       Date:  2014-08-01       Impact factor: 1.355

3.  Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramers.

Authors:  Maha Ayyoub; Danijel Dojcinovic; Pascale Pignon; Isabelle Raimbaud; Julien Schmidt; Immanuel Luescher; Danila Valmori
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

4.  A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.

Authors:  Abdullah Alsuliman; Muharrem Muftuoglu; Ahmad Khoder; Yong-Oon Ahn; Rafet Basar; Michael R Verneris; Pawel Muranski; A John Barrett; Enli Liu; Li Li; Kate Stringaris; Darius Armstrong-James; Hila Shaim; Kayo Kondo; Nobuhiko Imahashi; Borje Andersson; David Marin; Richard E Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

Review 5.  Epitope prediction and identification- adaptive T cell responses in humans.

Authors:  John Sidney; Bjoern Peters; Alessandro Sette
Journal:  Semin Immunol       Date:  2020-10-31       Impact factor: 11.130

Review 6.  Basic principles of tumor-associated regulatory T cell biology.

Authors:  Peter A Savage; Sven Malchow; Daniel S Leventhal
Journal:  Trends Immunol       Date:  2012-09-19       Impact factor: 16.687

7.  Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection.

Authors:  Afework Kassu; Roland A Marcus; Michelle B D'Souza; Elizabeth A Kelly-McKnight; Lucy Golden-Mason; Ramesh Akkina; Andrew P Fontenot; Cara C Wilson; Brent E Palmer
Journal:  J Immunol       Date:  2010-07-23       Impact factor: 5.422

Review 8.  High throughput T epitope mapping and vaccine development.

Authors:  Giuseppina Li Pira; Federico Ivaldi; Paolo Moretti; Fabrizio Manca
Journal:  J Biomed Biotechnol       Date:  2010-06-15

9.  New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation.

Authors:  Elise Landais; Pablo A Romagnoli; Adam L Corper; John Shires; John D Altman; Ian A Wilson; K Christopher Garcia; Luc Teyton
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  The curation guidelines of the immune epitope database and analysis resource.

Authors:  R Vita; B Peters; A Sette
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.